News
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
Discover how the WHO's new guidelines on lenacapavir could revolutionise HIV prevention, offering a long-acting alternative ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
22h
AllAfrica on MSNLenacapavir Offers Hope Against HIV, Now the World Must ActA new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by.Presented ...
3d
TheHealthSite on MSNWhat Is Lenacapavir? All About WHO Recommended Biannual HIV Prevention DrugA breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...
Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
Robert Garcia and Raja Krishnamoorthi accuse HHS of dismantling life-saving HIV programs based on conspiracy theories and ...
2d
AllAfrica on MSNKenya to Roll Out Long-Acting Injectable HIV Prep Lenacapavir By Jan 2026Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following ...
Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results